CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson’s disease?

Researchers utilize the CRISPR-Cas9 system to induce the synthesis of dopamine (DA) in the brains of a rat model for Parkinson’s disease.

Timing and cost of new vaccines vary by virus and health insurance status

As summer edges toward fall, thoughts turn to, well, vaccines.

August 24, 2023

Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle

Nearly a decade ago, venture capitalist Bob Nelsen called industry veteran Vicki Sato to pitch her on launching a large company dedicated to tackling the

April 15, 2024

Clinical Challenges: Test Your Knowledge of Crohn’s Disease

A MedPage Today Clinical Challenges series on Crohn’s disease reviewed novel therapeutic targets, managing pediatric disease, and the role of diet and nutrition. The following

December 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.